Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVAX Novavax

Market Closed 06-12 16:00:00 EDT

8.88

-0.15

-1.66%

盘后8.89

+0.01+0.16%

19:48 EDT

High9.30	Low8.80	Vol2.59M
Open9.07	D1 Closing9.03	Amplitude5.59%
Mkt Cap1.46B	Tradable Cap1.21B	Total Shares164.43M
T/O23.26M	T/O Rate1.90%	Tradable Shares136.72M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"Novavax","latestPrice":8.88,"timestamp":1781294400000,"preClose":9.03,"halted":0,"volume":2592147,"hourTrading":{"tag":"盘后","latestPrice":8.8939,"preClose":8.88,"latestTime":"19:48 EDT","volume":9605,"amount":85728.8984,"timestamp":1781308131223,"change":0.0139,"changeRate":0.001565,"amplitude":0.013514},"delay":0,"changeRate":-0.016611295681062968,"floatShares":136723812,"shares":164427429,"eps":-0.5784,"marketStatus":"Market Closed","change":-0.15,"latestTime":"06-12 16:00:00 EDT","open":9.07,"high":9.3,"low":8.795,"amount":23256328.14048,"amplitude":0.055925,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.5784,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.03,"preHourTrading":{"tag":"盘前","latestPrice":8.95,"preClose":9.03,"latestTime":"09:27 EDT","volume":10089,"amount":90869.746446,"timestamp":1781270831514,"change":-0.08,"changeRate":-0.008859,"amplitude":0.017021},"postHourTrading":{"tag":"盘后","latestPrice":8.8939,"preClose":8.88,"latestTime":"19:48 EDT","volume":9605,"amount":85728.8984,"timestamp":1781308131223,"change":0.0139,"changeRate":0.001565,"amplitude":0.013514},"volumeRatio":0.570707,"impliedVol":0.8616,"impliedVolPercentile":0.5817},"requestUrl":"/m/hq/s/NVAX/tweets","defaultTab":"tweets","newsList":[{"id":"2643318297","title":"Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2643318297","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643318297?lang=en_us&edition=fundamental","pubTime":"2026-06-13 01:20","pubTimestamp":1781284833,"startTime":"0","endTime":"0","summary":"Novavax (NVAX) is reshaping its business model after handing European commercialization of its COVID-19 vaccine to Sanofi and prioritizing partnerships that license out its Matrix-M adjuvant technology.\nSee our latest analysis for Novavax.\nRecent stock moves reflect that shift in focus. Despite a 1-day share price return of 5.49% to US$9.03, the 7-day and 90-day share price returns are down 11.38% and 11.77%. The year-to-date share price return of 26.65% sits alongside a 1-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/novavax-nvax-stock-revalued-after-pivot-to-sanofi-deal-and-m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/novavax-nvax-stock-revalued-after-pivot-to-sanofi-deal-and-m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4547","NVAX","SNYNF","BK4588","BK4568","BK4139","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642826426","title":"Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Novavax (NVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642826426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642826426?lang=en_us&edition=fundamental","pubTime":"2026-06-12 18:00","pubTimestamp":1781258436,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biomea Fusion (BMEA) and Novavax (NVAX) with bullish...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-novavax-nvax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-novavax-nvax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","NVAX","LU0128526141.USD","BK4588","BK4137","HCSG","LU0029874061.USD","XBI","BK4139","BMEA","BK4539","BK4568","BK4547","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642612172","title":"Novavax Price Target Maintained With a $19.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642612172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642612172?lang=en_us&edition=fundamental","pubTime":"2026-06-12 17:52","pubTimestamp":1781257920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NVAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 12, 2026 05:52 ET (09:52 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642232109","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232109?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:29","pubTimestamp":1781213340,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rose 5.49% to $9.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.54% to 25,809.66 and the Dow Jones Industrial Average  rising 1.86% to 50,848.75.Novavax Inc. closed 24.56% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.07% to $238.33, Pfizer Inc.  rose 2.23% to $26.17, and Merck & Co. Inc.  rose 1.40% to $120.76.Trading volume  remained 1.2 million below its 50-day average volume of 4.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVAX","BK4585","BK4547","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479411","title":"Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479411","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479411?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:28","pubTimestamp":1781126880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 1.27% to $8.56 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.98% to 25,169.50 and Dow Jones Industrial Average  falling 1.87% to 49,918.78.Novavax Inc. closed 28.49% below its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 0.63% to $238.49, Pfizer Inc.  fell 0.39% to $25.60, and Merck & Co. Inc.  fell 0.43% to $119.09.Trading volume  remained 1.7 million below its 50-day average volume of 4.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4588","BK4547","NVAX","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642243171","title":"Novavax Inc. Stock Sheds 9.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2642243171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642243171?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:33","pubTimestamp":1780950780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. slipped 9.2% to $8.62 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 25,929.66 and the Dow Jones Industrial Average falling 0.2% to 50,786.01.This was the stock's sixth consecutive day of losses.Novavax Inc. closed 28.0% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.3% to $232.16, Pfizer Inc. fell 1.6% to $25.62, and Merck & Co. Inc. fell 1.05% to $119.52.Trading volume totaled 6.8 million, compared to the 50-day average of 4.7 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4139","BK4588","BK4585","BK4568","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128599","title":"Novavax Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128599?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:28","pubTimestamp":1780694880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 6.87% to $9.49 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 4.18% to 25,709.43 and Dow Jones Industrial Average  falling 1.35% to 50,866.78.This was the stock's fifth consecutive day of losses.Novavax Inc. closed 20.72% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 2.02% to $232.77, Pfizer Inc.  rose 1.36% to $26.04, and Merck & Co. Inc.  rose 0.44% to $120.79.Trading volume  remained 108,989 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and T","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVY","BK4139","SDY","DJX","BK4568","NVAX","GRNY","VUG","TOPT","YMAX","SDOW","DGRW","MGK","BK4588","DOG","SCHD","BK4585","FDN",".DJI","DXD","MYMmain","BK4547","SCHG","VYMI","DGRO","DDM","FDVV","DIA","UDOW","XLI","VYM","DJIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641412591","title":"Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2641412591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641412591?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:30","pubTimestamp":1780677025,"startTime":"0","endTime":"0","summary":"Novavax ($NVAX) announced an update on their ongoing clinical study. The study, titled “A Randomized, Observer-Blinded, Active-Controlled Study to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novavaxs-combo-covid-19-and-flu-shot-trial-reaches-key-milestone-for-older-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novavaxs-combo-covid-19-and-flu-shot-trial-reaches-key-milestone-for-older-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4139","BNTX","BK4551","BK4585","BK4547","BK4548","BK4568","NVAX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641314125","title":"Novavax and Sanofi Advance Omicron JN.1 Booster With Completed Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641314125","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641314125?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:30","pubTimestamp":1780677011,"startTime":"0","endTime":"0","summary":"Novavax ($NVAX) announced an update on their ongoing clinical study. The Phase 3 study “A Phase 3 Open-Label, Single-Arm Study to Evaluate the Safe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novavax-and-sanofi-advance-omicron-jn-1-booster-with-completed-phase-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novavax-and-sanofi-advance-omicron-jn-1-booster-with-completed-phase-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4547","BK4568","BK4585","BK4588","BK4007","BK4139","NVAX","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640676679","title":"Novavax Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640676679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640676679?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:28","pubTimestamp":1780349280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 4.19% to $10.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.42% to 27,086.81 and the Dow Jones Industrial Average  rising 0.09% to 51,078.88.Novavax Inc. closed 12.20% below its 52-week high of $11.97, which the company reached on February 26th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.81% to $223.51, Pfizer Inc.  fell 2.10% to $25.63, and Merck & Co. Inc.  fell 2.99% to $115.17.Trading volume  remained 10,749 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4568","BK4588","BK4547","NVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696107","title":"Novavax to present at Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696107","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640696107?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:00","pubTimestamp":1780344039,"startTime":"0","endTime":"0","summary":"Novavax will participate in the 2026 Jefferies Global Healthcare Conference in New York on June 4, 2026.Management is scheduled for a fireside chat from 10:30 a.m. to 11:00 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL8YzTX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4568","BK4588","BK4585","BK4547","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639467769","title":"Novavax Inc. Stock Rallies 6.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639467769","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639467769?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:34","pubTimestamp":1780086840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. advanced 6.3% to $10.97 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,972.62 and the Dow Jones Industrial Average rising 0.7% to 51,032.46.Novavax Inc. closed 8.4% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its peers, as Johnson & Johnson fell 2.4% to $225.33, Pfizer Inc. rose 0.2% to $26.18, and Merck & Co. Inc. fell 0.98% to $118.72.Trading volume totaled 7.1 million, compared to the 50-day average of 4.6 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4547","BK4568","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639618234","title":"US FDA Advisers Vote in Favor of Recommending Covid Vaccines Target Jn.1 Lineage Xfg Variant for 2026-27 Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2639618234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639618234?lang=en_us&edition=fundamental","pubTime":"2026-05-29 02:26","pubTimestamp":1779992787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nFWN4250W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","LU0225284248.USD","SG9999002224.SGD","BK4548","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4139","BK4533","BK4599","NVAX","BK4501","LU1066053197.SGD","SG9999011175.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","LU0170899867.USD","LU0234572021.USD","LU0456855351.SGD","PFE","IE0002270589.USD","LU0868494617.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU0306807586.USD","LU1057294990.SGD","BK4532","BK4588","IE00BBT3K403.USD","BK4585","SG9999001176.SGD","LU0985481810.HKD","LU1023059063.AUD","LU0306806265.USD","BK4534","IE00BLSP4239.USD","MRNY","LU1894683348.USD","BK4592","BK4581","BK4550","IE00B19Z3B42.SGD","SG9999001176.USD","BK4547","SG9999003800.SGD","BK4007","SG9999002232.USD","SG9999013999.USD","LU1066051498.USD","BK4551","LU0321505868.SGD","LU0289739699.SGD","LU1883839398.USD","LU0122379950.USD","MRNX","LU1894683264.USD","BK4568","MRNA","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199656658","title":"Stock Track | Novavax Plummets 5.04% Intraday on FDA Vaccine Composition Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1199656658","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199656658?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:44","pubTimestamp":1779975862,"startTime":"0","endTime":"0","summary":"Novavax's stock plummeted 5.04% during intraday trading on Thursday, as investors reacted to regulatory uncertainty surrounding the composition of COVID-19 vaccines for the upcoming season.The U.S....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669353","title":"Sanofi Says Manufacturing Xfg Protein Nuvaxovid Vaccine as Its Single Global Covid-19 Product for the 2026-27 Season: Briefing Docs","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638669353?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:19","pubTimestamp":1779970779,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N425173:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","NVAX","BK4585","BK4547","BK4568","GCVRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638664846","title":"FDA advisers to weigh composition of COVID vaccines for 2026-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638664846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638664846?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:00","pubTimestamp":1779962400,"startTime":"0","endTime":"0","summary":"FDA advisers to weigh composition of COVID vaccines for 2026-2027By Christy Santhosh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N424142:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0058720904.USD","LU0306806265.USD","LU1066053197.SGD","SG9999002232.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0225771236.USD","LU0225284248.USD","IE00B3T34201.USD","BK4501","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4007","BK4581","LU1883839398.USD","IE00BLSP4452.SGD","LU0985481810.HKD","LU0321505439.SGD","BK4568","LU1057294990.SGD","SG9999001176.SGD","BK4548","MRNY","SG9999002224.SGD","SG9999011175.SGD","BK4592","BK4534","LU0456855351.SGD","BK4547","LU0289739699.SGD","LU0306807586.USD","LU0868494617.USD","LU1066051498.USD","BK4585","LU0170899867.USD","LU1894683348.USD","IE00BLSP4239.USD","LU1023059063.AUD","MRNX","BK4139","BK4551","SG9999001176.USD","SG9999013999.USD","LU0234572021.USD","BK4588","BK4533","BK4532","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0321505868.SGD","BK4550","BK4599","NVAX","PFE","MRNA","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638631348","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2638631348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638631348?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:28","pubTimestamp":1779917280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rallied 6.02% to $11.09 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.07% to 26,674.73 and the Dow Jones Industrial Average  rising 0.36% to 50,644.28.This was the stock's third consecutive day of gains.Novavax Inc. closed 7.35% below its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 0.48% to $231.29, Pfizer Inc.  rose 1.39% to $26.21, and Merck & Co. Inc.  rose 0.43% to $120.24.Trading volume  eclipsed its 50-day average volume of 4.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4547","BK4568","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638533528","title":"Novavax Inc. Stock Rallies 13.6%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2638533528","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638533528?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:33","pubTimestamp":1779827580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. jumped 13.6% to $10.46 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 26,656.18 and the Dow Jones Industrial Average falling 0.2% to 50,461.68.This was the stock's second consecutive day of gains.Novavax Inc. closed 12.6% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.6% to $230.18, Pfizer Inc. fell 0.2% to $25.85, and Merck & Co. Inc. fell 2.20% to $119.72.Trading volume totaled 8.2 million, compared to the 50-day average of 4.4 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVAX","BK4547","BK4568","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174175690","title":"Stock Track | Novavax Soars 12.54% as FDA Considers XFG-Targeted COVID Vaccine Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1174175690","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174175690?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:35","pubTimestamp":1779809715,"startTime":"0","endTime":"0","summary":"Novavax's stock surged 12.54% intraday on Tuesday as investors reacted to regulatory developments regarding COVID-19 vaccine formulations.The U.S. Food and Drug Administration's advisory committee is...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638954371","title":"US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2638954371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638954371?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:52","pubTimestamp":1779807176,"startTime":"0","endTime":"0","summary":"US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be upd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4N4230ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","SG9999003800.SGD","LU1894683264.USD","IE00B19Z3581.USD","LU0234572021.USD","MRNX","BK4532","SG9999013999.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1066051498.USD","BK4592","BK4551","BK4547","LU0058720904.USD","LU0321505868.SGD","SG9999001176.USD","NVAX","LU0225284248.USD","SG9999001176.SGD","LU0456855351.SGD","BK4548","IE00B19Z3B42.SGD","LU0225771236.USD","BK4550","LU0306807586.USD","SGXZ57979304.SGD","LU0122379950.USD","BK4534","MRNA","BK4139","LU0985481810.HKD","SG9999002224.SGD","PFE","LU1023059063.AUD","LU0170899867.USD","LU1066053197.SGD","MRNY","IE00B3T34201.USD","IE00BBT3K403.USD","LU0321505439.SGD","BK4533","BK4501","LU1057294990.SGD","BK4568","LU0289739699.SGD","LU1883839398.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU1894683348.USD","SG9999002232.USD","BK4585","BK4581","IE0002270589.USD","BK4588","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":-0.1138},{"period":"1month","weight":-0.0613},{"period":"3month","weight":-0.1177},{"period":"6month","weight":0.3744},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.3437}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.677419,"avgChangeRate":0.108114},{"month":2,"riseRate":0.580645,"avgChangeRate":0.042802},{"month":3,"riseRate":0.258065,"avgChangeRate":-0.045948},{"month":4,"riseRate":0.451613,"avgChangeRate":0.007887},{"month":5,"riseRate":0.548387,"avgChangeRate":0.134336},{"month":6,"riseRate":0.483871,"avgChangeRate":0.081748},{"month":7,"riseRate":0.566667,"avgChangeRate":0.019422},{"month":8,"riseRate":0.533333,"avgChangeRate":0.039885},{"month":9,"riseRate":0.5,"avgChangeRate":-0.036425},{"month":10,"riseRate":0.3,"avgChangeRate":0.027361},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.003351},{"month":12,"riseRate":0.366667,"avgChangeRate":-0.038609}],"exchange":"NASDAQ","name":"Novavax","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Novavax(NVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Novavax,NVAX,Novavax股票,Novavax股票老虎,Novavax股票老虎国际,Novavax行情,Novavax股票行情,Novavax股价,Novavax股市,Novavax股票价格,Novavax股票交易,Novavax股票购买,Novavax股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Novavax(NVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction